Clinical Trials Logo

Filter by:
NCT ID: NCT03127267 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Start date: February 2, 2021
Phase: Phase 3
Study type: Interventional

The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for the treatment of Amyotrophic Lateral Sclerosis (ALS).

NCT ID: NCT03124082 Recruiting - Postoperative Pain Clinical Trials

OFA - Opioid Free Anesthesia

OFA
Start date: January 4, 2017
Phase: Phase 4
Study type: Interventional

Opioids have been used for analgesia since many years, but despite potent analgesia they are also associated to side effects, including opioid induced Hyperalgesia (OIH). OIH in the surgical setting is debated, and may predispose patients to higher analgesic consumption in the preoperative period, and peripheral and central sensitization. The aim of the study is to compare remifentanil-based vs non opioid analgesia (clonidine, lidocaine, ketamine) for intraoperative management of patients undergoing laparoscopic left hemicolectomy, with the hypothesis that non- opiod treated patients will have lower morphine consumption in the first 24 hours after surgery. Peripheral and central hyperalgesia will be tested with Von Frey hairs and pin-prick to evaluate acute CNS (Central Nervous System) sensitization after surgery. Acute and persistent (1 and 3 months) pain will be registered, together with any side effect and parameters of surgical rehabilitation.

NCT ID: NCT03124030 Recruiting - Dental Diseases Clinical Trials

Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

NOADB
Start date: August 2, 2016
Phase: N/A
Study type: Observational

Direct Oral Anticoagulants were recently approved for medical treatment of several condition such as, non valvular atrial fibrillation, deep venous thrombosis, and others, substituting sometimes the conventional oral anticoagulants. The aim of the present study is to observe the possible difference in intra-operative and post-operative bleeding events for single dental extraction.

NCT ID: NCT03124004 Recruiting - Clinical trials for Periodontal Diseases

Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients

NOADB_db
Start date: August 15, 2016
Phase: N/A
Study type: Observational

Direct Oral Anticoagulants were recently approved for medical treatment of several condition such as, non valvular atrial fibrillation, deep venous thrombosis, and others, substituting sometimes the conventional oral anticoagulants. The aim of the present study is to observe the possible difference in intra-operative and post-operative bleeding events for periodontal debridement.

NCT ID: NCT03119402 Recruiting - Clinical trials for Developmental Dyslexia

Effects of the Combination of RRT With tDCS on Dyslexic Adults

Start date: April 18, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of the combination of Rhythmic Reading Training (RRT), a computer-assisted intervention method that combines sublexical reading exercises with rhythm processing, and transcranial direct current stimulation (tDCS) on reading abilities of a group of Italian undergraduate students with dyslexia. Two experimental conditions (active vs. sham) will be compared. Finally, the effects of the intervention on other cognitive functions involved in the process of reading (i.e., rapid automatized naming, verbal working memory, rhythm perception abilities) will be measured.

NCT ID: NCT03117608 Recruiting - Clinical trials for Osteoarthritis, Knee

A Single Intra-articular Injection of aMAT vs PRP in Patients With OA of the Knee

LIPOJOINT
Start date: February 24, 2017
Phase: Phase 4
Study type: Interventional

The study proposes to compare performances and safety of intra-articular injections of aMAT with those of a control group (PRP injections) for the treatment of symptomatic OA of the knee. The end-points will be determined evaluating the performances of the treatment group in terms of improvement of the symptomatology, functional recovery and radiological appearance.

NCT ID: NCT03116217 Recruiting - Clinical trials for Posterior Urethral Valves

Validation of a Fetal Urine Peptidome-based Classifier to Predict Post-natal Renal Function in Posterior Urethral Valves

Antenatal
Start date: June 26, 2017
Phase:
Study type: Observational

Validate the use of fetal urine peptidome-analysis and explore amniotic fluid markers for the stratification of fetuses with Posterior Urethral Valve for post-natal renal function.

NCT ID: NCT03113435 Recruiting - Clinical trials for Hemodynamic Instability

Patient Management During Major Abdominal Surgery: an Oxygen Consumption Protocol Compared to Standard Approach

HEART-CORE
Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This study compares the actual standard of care with a new protocol to guide hemodynamic optimization during major abdominal surgery, which is more tailored on patient real needs. During general anesthesia metabolic needs of the body are markedly reduced and increase in CO may not be necessary. In addition, excessive fluid administration has been related to worse post-operative outcomes. We divide patients into three groups: the standard treatment group, the NICE protocol group and the intervention group. In this group we use the v-aCO2/CaO2-CvO2 as marker of tissue ability to increase their oxygen consumption in response to increased O2 delivery, and based on this index the administration of fluid. The principal aim is to optimize functional hemodynamics in order to reduce the fluid balance at the end of the surgery.

NCT ID: NCT03112707 Recruiting - Clinical trials for Coronary Artery Disease

Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT

POEM
Start date: April 14, 2017
Phase: Phase 4
Study type: Interventional

Objective: To evaluate the safety of bioresorbable polymer-coated everolimus-eluting Synergy® stent followed by 1-month dual antiplatelet therapy in patients at high-bleeding risk. Study population: Real world high-bleeding risk (HBR) patients with coronary artery disease (stable as well as acute coronary syndromes) who qualify for percutaneous coronary interventions. Study size: A total of 1023 patients will be enrolled. Study design: Prospective, single-arm, multicentre trial, powered for non-inferiority with respect to objective performance criteria (OPC). Antiplatelet therapy: Dual antiplatelet therapy with aspirin 100 mg od and a P2Y12 inhibitor for a duration of 1 month, after which single antiplatelet therapy with aspirin will be recommended indefinitely. In case of need for oral anticoagulation, patients will receive an oral anticoagulant in addition to a P2Y12 inhibitor without aspirin for 30 days. Primary endpoint: Composite of cardiac death, myocardial infarction, or definite/probable stent thrombosis at 1-year follow-up.

NCT ID: NCT03110796 Recruiting - Diabetic Foot Ulcer Clinical Trials

Assessment of the Efficacy and Safety of a New Medical Device in the Local Treatment of Diabetic Foot Ulcers

DISCOVERY
Start date: July 31, 2017
Phase: N/A
Study type: Interventional

Evaluation of the efficacy and safety of a device with LU3103209 compound versus the same device, free of LU3103209 compound, in the local management of DFUs.